Navigation Links
Dacogen comes to the rescue of MDS

Myelodysplastic syndromes (MDS) is a type of disorder in which in which the bone marrow stops producing mature Red blood cells (RBC). Due to this the patients lack enough// number of RBCs and resulting in improper functioning of the body. Typical symptoms include weakness, fatigue, infections, easy bruising, bleeding, and fever. Hence the Food and Drug Administration approved Dacogen injections for the treatment of MDS.

These injections promote the normal development of blood cells. The FDA has given the drug an orphan drug status. This is because it is used in the treatment of rare diseases or conditions that affect fewer than 200,000 people in the U.S. the approval has been an alternative for people suffering from MDS as they can avoid blood transfusions says Steven Galson, MD, Director of FDA's Center for Drug Evaluation and Research. As of now there is no clear evidence for the cause of MDS. They can develop following treatment with drugs or radiation therapy for other diseases and can progress to acute myeloid leukemia (AML). Statistics show that about 7,000 to 12,000 new cases are diagnosed yearly in the US.
'"/>




Page: 1

Related medicine news :

1. Now AIDS treatment comes dirt-cheap
2. Shorter infants have lower incomes in later life
3. Joint replacement surgery outcomes may be affected by obesity and diabetes
4. When it comes to health, all chocolates not the same.
5. Enhanced Gene Therapy Outcomes Following Latest Revolution And Refinement
6. Gene Therapy Overcomes Heart Failure In Muscular Dystrophy
7. Testicular Cancer Patients Have Improved Reproductive Outcomes After Treatment
8. India becomes a member of IARC
9. PET Scans Could Predict Treatment Outcomes In Cancer
10. Nutrigenomics here comes a team to better your future!
11. Inhuman Error: Medicine Becomes Poison, Causing Death
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, ... dedicated to helping service members that have been wounded in battle and their families. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: